Literature DB >> 29268133

Targeting pattern-recognition receptors to discover new small molecule immune modulators.

Gengzheng Zhu1, Yao Xu1, Xiaohong Cen1, Kutty Selva Nandakumar1, Shuwen Liu2, Kui Cheng3.   

Abstract

Pattern recognition receptors (PRRs) are key immune receptors of the innate immune system, which recognize the conserved pathogen-associated molecular patterns (PAMPs) of the invading pathogens. Compared to the adaptive immune receptors, PRRs have three distinguishing features, viz., universal expression, fast response and recognizing many kinds of microbes. Toll-like receptors (TLRs), RIG-I-like receptors (RLRs), C-type lectin receptors (CLRs) and NOD-like receptors (NLRs) recognize viral nucleic acid/bacterial fragments and trigger anti-microbial innate immune responses. Upon recognition of their ligand species, PRRs recruit specific intracellular adaptor proteins to initiate signaling pathways culminating in the activation of nuclear factor-κB (NF-κB), mitogen-activated protein (MAP) kinases and interferon regulatory factors (IRFs) that control the transcription of genes encoding pro-inflammatory factors including type I interferon and other inflammatory cytokines, which are critical for eliminating the potential threat to the host. Here, we summarize the effects of small molecule regulators acting on signaling pathways initiated by TLR, RLR and NLR as well as their influence on innate and adaptive immune responses leading to therapy.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  NOD-like receptors (NLRs); Pattern-recognition receptors (PRRs); RIG-I-like receptors (RLRs); Small molecule modulators; Toll-like receptors (TLRs)

Mesh:

Substances:

Year:  2017        PMID: 29268133     DOI: 10.1016/j.ejmech.2017.12.026

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  19 in total

Review 1.  Post-Translational Modifications of STING: A Potential Therapeutic Target.

Authors:  Jiaqi Kang; Jie Wu; Qinjie Liu; Xiuwen Wu; Yun Zhao; Jianan Ren
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

Review 2.  NOD-like receptors in autoimmune diseases.

Authors:  Li Chen; Shi-Qi Cao; Ze-Min Lin; Shi-Jun He; Jian-Ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2021-02-15       Impact factor: 6.150

3.  β-Hydroxybutyrate, One of the Three Main Ketone Bodies, Ameliorates Acute Pancreatitis in Rats by Suppressing the NLRP3 Inflammasome Pathway.

Authors:  Erhan Şahin; N Ezgi Bektur Aykanat; Sedat Kacar; Rıdvan Bagci; Varol Sahinturk
Journal:  Turk J Gastroenterol       Date:  2021-08       Impact factor: 1.852

Review 4.  Targeting IgG in Arthritis: Disease Pathways and Therapeutic Avenues.

Authors:  Kutty Selva Nandakumar
Journal:  Int J Mol Sci       Date:  2018-02-28       Impact factor: 5.923

Review 5.  RNase T2 in Inflammation and Cancer: Immunological and Biological Views.

Authors:  Lei Wu; Yanquan Xu; Huakan Zhao; Yongsheng Li
Journal:  Front Immunol       Date:  2020-08-13       Impact factor: 7.561

6.  Influenza Virus-Induced Robust Expression of SOCS3 Contributes to Excessive Production of IL-6.

Authors:  Shasha Liu; Ruoxiang Yan; Biao Chen; Qidong Pan; Yuhai Chen; Jinxuan Hong; Lianfeng Zhang; Wenjun Liu; Song Wang; Ji-Long Chen
Journal:  Front Immunol       Date:  2019-08-16       Impact factor: 7.561

7.  The Role of Reactive Oxygen Species and Nitric Oxide in the Inhibition of Trichophyton rubrum Growth by HaCaT Cells.

Authors:  Meiling Huang; Hao Huang; Wenyi Lv; Hanyue Xiao; Ye Gao; Hongfeng Tang
Journal:  Oxid Med Cell Longev       Date:  2020-02-12       Impact factor: 6.543

8.  Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific Manner.

Authors:  Jinu Abraham; Sara Botto; Nobuyo Mizuno; Kara Pryke; Bryan Gall; Dylan Boehm; Tina M Sali; Haihong Jin; Aaron Nilsen; Michael Gough; Jason Baird; Marita Chakhtoura; Caroline Subra; Lydie Trautmann; Elias K Haddad; Victor R DeFilippis
Journal:  Front Immunol       Date:  2020-07-08       Impact factor: 7.561

9.  Biological Characterization, Mechanistic Investigation and Structure-Activity Relationships of Chemically Stable TLR2 Antagonists.

Authors:  Marcel Bermudez; Maria Grabowski; Manuela S Murgueitio; Markus Tiemann; Péter Varga; Thomas Rudolf; Gerhard Wolber; Günther Weindl; Jörg Rademann
Journal:  ChemMedChem       Date:  2020-06-03       Impact factor: 3.466

Review 10.  Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development.

Authors:  Knut Biber; Anindya Bhattacharya; Brian M Campbell; Justin R Piro; Michael Rohe; Roland G W Staal; Robert V Talanian; Thomas Möller
Journal:  Front Pharmacol       Date:  2019-08-23       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.